首页> 外国专利> N-SULFONYLINDOLINE DERIVATIVES CARRYING AN AMIDE FUNCTIONAL GROUP, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS IN WHICH THEY ARE PRESENT

N-SULFONYLINDOLINE DERIVATIVES CARRYING AN AMIDE FUNCTIONAL GROUP, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS IN WHICH THEY ARE PRESENT

机译:带有酰胺功能基团的N-磺基吲哚啉衍生物,其制备和目前存在的药物成分

摘要

Compounds of formula (6): 6in whichA' is NR6R7;- R1 is a halogen atom, a C1-C4 alkyl, a hydroxyl, aC1-C4 alkoxy, a benzyloxy group, a cyano group, atrifluoromethyl group, nitro group or an aminogroup;- R2 is a C1-C6 alkyl, a C3-C7 cycloalkyl, a C5-C7cycloalkene or a phenyl which is unsubstituted ormonosubstituted or polysubstituted by a C1-C4alkyl, a C1-C4 alkoxy, a halogen, a trifluoromethylgroup or an amino group, or R2 is a nitrophenylwhich is unsubstituted or monosubstituted by atrifluoromethyl group or monosubstituted orpolysubstituted by a C1-C4 alkyl, a C1-C4 alkoxy ora halogen;- R5 is a C1-C4 alkyl; a 1-naphthyl; a 2-naphthyl; a5-dimethylamino-1-naphthyl; a phenyl which isunsubstituted or substituted by one or moresubstituents selected from a halogen atom, a C1-C4alkyl, a trifluoromethyl group, an amino groupwhich is free or substituted by one or two C1-C4alkyls, a hydroxyl, a C1-C4 alkoxy, a C2-C4alkenoxy, a C1-C4 alkylthio, a trifluoromethoxygroup, a benzyloxy group, a cyano group, acarboxyl group, a C1-C4 alkoxycarbonyl group, a87carbamoyl group which is free or substituted byone or two C1-C4 alkyls or a C1-C4 alkylamidogroup, or R5 is a nitrophenyl which isunsubstituted or monosubstituted by atrifluoromethyl group or a C2-C4 alkenoxy ormono- or polysubstituted by a halogen, a C1-C4 alkyl, aC1-C4 alkoxy, a C1-C4 alkylthio, a trifluoromethoxygroup or a benzyloxy group;- R6 is a C1-C6 alkyl or R6 is identical to R7;- R7 is a 4-piperidyl group or a 3-azetidinyl group,the said groups being substituted or unsubstitutedon the nitrogen by a C1-C4 alkyl, by abenzyloxycarbonyl or by a C1-C4 alkoxycarbonyl; agroup (CH2)r which is itself substituted by a 2-,3- or 4-pyridyl group, by a hydroxyl group or byan amino group which is free or substituted by oneor two C1-C4 alkyls, a carboxyl group, a C1-C4alkoxycarbonyl group, a benzyloxycarbonyl group ora carbamoyl group which is free or substituted byone or two C1-C4 alkyls;- or R6 and R7 together, with the nitrogen atom towhich they are connected, form a heterocycleselected from:. morpholine,. thiomorpholine,. thiazolidine or 2,2-dimethylthiazolidine,unsubstituted or substituted by R8,. piperazine, unsubstituted or substituted at the4-position by a group R"8,. an unsaturated, a 5-membered ring containing asingle nitrogen atom and substituted by R8 or asaturated, 3-, 4-, 5-, 6- or 7-membered ringcontaining a single nitrogen atom andsubstituted by R8 and R9;- R8 is R'8 or a group (CH2)r which is itselfsubstituted by a hydroxyl or by an amino which isfree or substituted by one or two C1-C4 alkyls;88- R'8 is a group (CH2)q which is itself substitutedby a carboxyl group, a C1-C4 alkoxycarbonyl group,a benzyloxycarbonyl group, a carbamoyl group whichis free or substituted by a hydroxyl or by one ortwo C1-C4 alkyls or an aminocarbothioyl group whichis free or substituted by one or two C1-C4 alkyls;- R"8 is R'8 or a group (CH2)2NH2 which is free orsubstituted by one or two C1-C4 alkyls;- R9 is hydrogen, a halogen, a group (CH2) rOR10, agroup (CH2)rNR11R12, a group (CH2)sCONR11R'11 or anazido group;- R10 is hydrogen, a C1-C4 alkyl, a mesyl or a tosyl;- R11, R'11 and R12 are each a hydrogen or a C1-C4alkyl or R11 is hydrogen and R12 is abenzyloxycarbonyl or a C1-C4 alkoxycarbonyl;- n is 0, 1 or 2;- m is 0, 1 or 2;- q is 0, 1, 2 or 3;- r is 0, 1, 2 or 3, with the limitation that r isnot zero when R8 or R9 is at the alpha-position ofthe intracyclic amide nitrogen;- s is 0 or 1;are useful as intermediates of the preparation ofN-sulfonylindoline derivatives which are useful in thetreatment of complaints of the central nervous system,the cardiovascular system and the gastric sphere inhumans and animals.
机译:式(6)的化合物: 6在其中A'是NR6R7;-R1是卤素原子,C1-C4烷基,羟基,aC 1 -C 4烷氧基,苄氧基,氰基,三氟甲基,硝基或氨基组;-R2是C1-C6烷基,C3-C7环烷基,C5-C7环烯或未取代的苯基或被C1-C4单取代或多取代烷基,C1-C4烷氧基,卤素,三氟甲基基或氨基,或R2为硝基苯基未取代或被一个单取代三氟甲基或单取代或被C1-C4烷基,C1-C4烷氧基或卤素;-R5是C1-C4烷基; 1-萘基; 2-萘基;一种5-二甲基氨基-1-萘基;苯基是未取代或被一个或多个取代选自卤素原子,C 1 -C 4的取代基烷基,三氟甲基,氨基游离或被一个或两个C1-C4取代烷基,羟基,C1-C4烷氧基,C2-C4烯氧基,C 1 -C 4烷硫基,三氟甲氧基基,苄氧基,氰基,羧基,C1-C4烷氧羰基,87游离或被取代的氨基甲酰基一个或两个C1-C4烷基或C1-C4烷基酰胺基或R5是硝基苯基未取代或被一个取代三氟甲基或C2-C4烷氧基或被卤素,C1-C4烷基,C 1 -C 4烷氧基,C 1 -C 4烷硫基,三氟甲氧基基团或苄氧基;-R6为C1-C6烷基或R6与R7相同;-R7是4-哌啶基或3-氮杂环丁烷基,所述基团被取代或未被取代在氮上由一个C1-C4烷基,一个苄氧羰基或由C1-C4烷氧羰基;一种(CH2)r基团,其本身被2-取代,3-或4-吡啶基,通过羟基或通过游离或被一个取代的氨基或两个C1-C4烷基,一个羧基,一个C1-C4烷氧羰基,苄氧羰基或游离或被取代的氨基甲酰基一个或两个C1-C4烷基;-或R6和R7与氮原子一起它们连接在一起,形成杂环选自:。吗啉。硫吗啉。噻唑烷或2,2-二甲基噻唑烷未取代或被R8取代,。未取代或在取代时被取代的哌嗪由R“ 8组的4位。一个不饱和的5元环一个氮原子并被R8或a取代饱和,3、4、5、6或7元环含有一个氮原子由R8和R9取代;-R8是R'8或本身是基团(CH2)r被羟基或氨基取代的是游离的或被一个或两个C 1 -C 4烷基取代;88-R'8是本身被取代的基团(CH2)q通过羧基,C 1 -C 4烷氧羰基,苄氧羰基,氨基甲酰基游离或被羟基或一个或多个取代两个C1-C4烷基或一个氨基碳硫基,其中游离或被一个或两个C1-C4烷基取代;-R“ 8是R'8或自由的基团(CH2)2NH2或被一个或两个C1-C4烷基取代;-R9是氢,卤素,基团(CH2)rOR10,(CH2)rNR11R12组,(CH2)sCONR11R'11组或叠氮基组-R 10为氢,C 1 -C 4烷基,甲磺酰基或甲苯磺酰基;-R11,R'11和R12分别是氢或C1-C4烷基或R11为氢,R12为苄氧羰基或C1-C4烷氧羰基;-n为0、1或2;-m为0、1或2;-q是0、1、2或3;-r为0、1、2或3,但限制为当R8或R9在以下位置时不为零环内酰胺氮;-s为0或1;可用作制备的中间体N-磺酰胆碱衍生物可用于治疗中枢神经系统的不适,心血管系统和胃球人类和动物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号